Researchers at the University of California, Irvine, have made significant strides in the field of pediatric cardiology with the preclinical testing of a groundbreaking heart valve replacement, specifically designed for toddlers and young children suffering from congenital cardiac defects. This development, which holds the potential to transform the lives of countless children, marks a pivotal moment in the quest for safer, less invasive surgical alternatives for managing congenital heart disease. Read More